In a revelation that has ignited fresh concerns and public debate, former and potentially future U.S. President Donald Trump has admitted to consuming a significantly higher daily dose of aspirin than medically recommended. The 79-year-old leader made this disclosure during an interview with The Wall Street Journal, stating his desire to maintain "nice & thin blood."
Defying Medical Advice for "Thin Blood"
The interview, which took place recently, saw Trump openly confess to his self-prescribed regimen. His personal physician has confirmed that the President ingests 325 milligrams of aspirin every day. This dosage is substantially higher than the standard low-dose aspirin, typically 81 milligrams, which is often recommended for cardiovascular prevention in older adults. Trump's justification, aimed at achieving thinner blood, goes directly against the counsel of his doctors, raising red flags among medical professionals.
A Pattern of Health Headlines and Public Scrutiny
This latest admission does not exist in a vacuum. It adds to a growing list of health-related incidents that have put Trump's physical condition under the microscope. Reports have recently surfaced about unexplained hand bruising, a condition that can sometimes be associated with blood thinners. Furthermore, he has been diagnosed with chronic venous insufficiency, a circulatory condition affecting the legs.
The scrutiny intensified with news of advanced medical imaging conducted at the Walter Reed National Military Medical Center, details of which remain private. Perhaps most visually striking was the viral footage from a recent cabinet meeting, where Trump appeared to doze off, fueling discussions about his stamina and alertness. These events collectively paint a picture that has both supporters and critics intensely debating his fitness for office.
Medical Risks and Political Repercussions
Doctors warn that unsupervised high-dose aspirin use, especially at 79, carries serious risks. Potential complications include:
- Increased risk of gastrointestinal bleeding and ulcers.
- Higher chance of hemorrhagic stroke due to excessive blood thinning.
- Adverse interactions with other medications.
- Kidney damage with long-term, high-dose use.
Politically, this revelation feeds into the ongoing narrative about transparency and judgment. As the second-oldest president in American history, any health disclosure is magnified. The choice to publicly defy medical expertise on a matter as sensitive as blood thinners is seen by analysts as a double-edged sword—portraying an image of self-reliance to his base while alarming others about potential recklessness.
The story, first reported by TOI on January 2, 2026, continues to develop as medical experts and political commentators weigh in on the implications of a world leader personally managing a potent medication against expert advice.
